NCT06346405

Central Serous Chorioretinopathy and Micropulse Laser Treatment

Central Serous Chorioretinopathy and Micropulse Laser Treatment: Evaluation of Morphological and Functional Recovery

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 36 (estimated)
• Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: —

Summary

To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone

Conditions

• Central Serous Chorioretinopathy

Interventions

Type	Name	Description
OTHER	Subthreshold Micropulse Laser Treatment	Subthreshold micropulse laser treatment consists in 33 spots of 100 microns, distance among each spot of 2.50 microns, duration of 200 sec, power of 250 milliwatt (mW) duty cycle 5%.

Timeline

• Start date: 2023-05-31
• Primary completion: 2027-05-31
• Completion: 2027-05-31
• First posted: 2024-04-04
• Last updated: 2025-09-23

Locations

1 site across 1 country: Italy